- Home
- RAPT vs ACR Comparison
RAPT vs ACR Comparison
Compare RAPT & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- ACR
- Stock Information
- Founded
- RAPT 2015
- ACR 2005
- Country
- RAPT United States
- ACR United States
- Employees
- RAPT N/A
- ACR N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- ACR Real Estate Investment Trusts
- Sector
- RAPT Health Care
- ACR Real Estate
- Exchange
- RAPT Nasdaq
- ACR Nasdaq
- Market Cap
- RAPT 117.5M
- ACR 139.0M
- IPO Year
- RAPT 2019
- ACR N/A
- Fundamental
- Price
- RAPT $7.35
- ACR $17.30
- Analyst Decision
- RAPT Buy
- ACR Buy
- Analyst Count
- RAPT 5
- ACR 2
- Target Price
- RAPT $42.00
- ACR $17.50
- AVG Volume (30 Days)
- RAPT 120.8K
- ACR 38.5K
- Earning Date
- RAPT 08-07-2025
- ACR 07-30-2025
- Dividend Yield
- RAPT N/A
- ACR N/A
- EPS Growth
- RAPT N/A
- ACR N/A
- EPS
- RAPT N/A
- ACR 0.34
- Revenue
- RAPT N/A
- ACR $83,545,000.00
- Revenue This Year
- RAPT N/A
- ACR $3.57
- Revenue Next Year
- RAPT N/A
- ACR N/A
- P/E Ratio
- RAPT N/A
- ACR $50.39
- Revenue Growth
- RAPT N/A
- ACR 6.92
- 52 Week Low
- RAPT $5.67
- ACR $12.70
- 52 Week High
- RAPT $30.60
- ACR $23.81
- Technical
- Relative Strength Index (RSI)
- RAPT 43.57
- ACR 34.98
- Support Level
- RAPT $6.88
- ACR $17.64
- Resistance Level
- RAPT $8.91
- ACR $18.06
- Average True Range (ATR)
- RAPT 0.70
- ACR 0.56
- MACD
- RAPT -0.16
- ACR -0.07
- Stochastic Oscillator
- RAPT 11.36
- ACR 0.26
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About ACR ACRES Commercial Realty Corp.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.